TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
TALPHERA, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.08+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $81.57M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.01 (+0.93%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
TALPHERA, INC. saw revenue fall 96.3% to $1.00K over the twelve months to Jun 30, 2026.
Revenue
$1.00K
-96.3% vs. a year earlier
Operating income
-$14.75M
TTM Q2 2026
EPS, diluted
-$0.27
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $81.57M
- P/E ratio
- –
- Price to sales
- 81569.05
- Price to book
- 5.66
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $1.00K
- Net income
- -$15.08M
- EPS, diluted
- -$0.27
- Book value per share
- $0.19
- Diluted shares
- 76M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$1.00K-96.3% YoY
Gross profit
–
Operating income
-$14.75M
Net income
-$15.08M
EPS, diluted
-$0.27
Free cash flow
–
Reported periodTrailing twelve months